Dana Farber Cancer Institute Dept of Sarcoma Oncology — Boston, Massachusetts

Dana Farber Cancer Institute Dept of Sarcoma Oncology is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Dept of Sarcoma Oncology has participated in 2 clinical trials.

Therapeutic areas: Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Dept of Sarcoma Oncology?

Dana Farber Cancer Institute Dept of Sarcoma Oncology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Dept of Sarcoma Oncology conducted?

Dana Farber Cancer Institute Dept of Sarcoma Oncology has 2 clinical trials on record. Their work covers Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Tumors.

Is Dana Farber Cancer Institute Dept of Sarcoma Oncology accredited by Crixeo Health?

Dana Farber Cancer Institute Dept of Sarcoma Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Dept of Sarcoma Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.